[go: up one dir, main page]

AU2690684A - Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin - Google Patents

Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin

Info

Publication number
AU2690684A
AU2690684A AU26906/84A AU2690684A AU2690684A AU 2690684 A AU2690684 A AU 2690684A AU 26906/84 A AU26906/84 A AU 26906/84A AU 2690684 A AU2690684 A AU 2690684A AU 2690684 A AU2690684 A AU 2690684A
Authority
AU
Australia
Prior art keywords
skin
treatment
methods
pharmaceutical compositions
hyperplastic diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26906/84A
Inventor
Kenji Adachi
Kenneth M. Halprin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to PCT/US1984/000291 priority Critical patent/WO1985003637A1/en
Priority to AU26906/84A priority patent/AU2690684A/en
Publication of AU2690684A publication Critical patent/AU2690684A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU26906/84A 1984-02-24 1984-02-24 Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin Abandoned AU2690684A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/US1984/000291 WO1985003637A1 (en) 1984-02-24 1984-02-24 Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
AU26906/84A AU2690684A (en) 1984-02-24 1984-02-24 Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1984/000291 WO1985003637A1 (en) 1984-02-24 1984-02-24 Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
AU26906/84A AU2690684A (en) 1984-02-24 1984-02-24 Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin

Publications (1)

Publication Number Publication Date
AU2690684A true AU2690684A (en) 1985-09-10

Family

ID=32657307

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26906/84A Abandoned AU2690684A (en) 1984-02-24 1984-02-24 Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin

Country Status (2)

Country Link
AU (1) AU2690684A (en)
WO (1) WO1985003637A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU591196B2 (en) * 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives
DE3623300A1 (en) * 1986-07-11 1988-01-21 Hoechst Ag 7-ACYLOXY-6-AMINOACYLOXYPOLYOXYLABDANE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
US4740522A (en) * 1986-08-28 1988-04-26 Hoechst-Roussel Pharmaceuticals Inc. Oxolabdanes useful as pharmaceuticals for reducing intraocular pressure
US5247097A (en) * 1986-08-28 1993-09-21 Hoechst-Roussel Pharmaceuticals Incorporated Oxolabdanes
DE3867710D1 (en) * 1987-06-01 1992-02-27 Keikichi Sugiyama COMPOSITION FOR APPLICATION ON HAIR AND SCALP.
DE3730748A1 (en) * 1987-06-06 1988-12-22 Hoechst Ag NEW POLYOXYGENATED LABDANE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
US5302730A (en) * 1987-06-29 1994-04-12 Nippon Kayaku Kk Process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives
HU201921B (en) * 1987-06-29 1991-01-28 Nippon Kayaku Kk New process for producing 6-acylforscholine derivatives
EP0448029B1 (en) * 1990-03-23 1995-12-20 Nippon Kayaku Kabushiki Kaisha Novel pharmaceutical uses of forskolin derivatives
FR2749168B1 (en) * 1996-05-30 1998-08-21 Lvmh Rech USE OF FURANOID LABDANE DITERPENOIDS FOR THE PREPARATION OF COSMETIC OR PHARMACEUTICAL COMPOSITIONS AND OF CELL CULTURE MEDIA
GB2333041A (en) * 1998-01-13 1999-07-14 Johnson & Johnson Medical Ltd Wound Composition
WO2000069406A1 (en) * 1999-05-18 2000-11-23 The Procter & Gamble Company Methods of regulating the condition of mammalian keratinous tissue
AU2002229611A1 (en) * 2000-12-08 2002-06-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of active compounds capable of modulating the intracellular pathway triggered by the dp receptor in langerhans cells
AU2009262729B2 (en) * 2008-06-25 2013-11-14 Elc Management Llc Method and compositions for improving skin and body appearance
US20220079915A1 (en) * 2018-12-29 2022-03-17 Shanghai Archeus Biotech Co., Ltd. Immunosuppressive pharmaceutical composition and application thereof
CN115414348A (en) * 2022-06-27 2022-12-02 昆明医科大学 Application of forskolin and its derivatives in the preparation of medicines for treating psoriasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2557784C2 (en) * 1975-12-22 1986-04-17 Hoechst Ag, 6230 Frankfurt Forskolin, process for obtaining it and pharmaceutical preparations containing this compound
DE2654796A1 (en) * 1976-12-03 1978-06-08 Hoechst Ag POLYOXYGENATED LABDAN DERIVATIVES

Also Published As

Publication number Publication date
WO1985003637A1 (en) 1985-08-29

Similar Documents

Publication Publication Date Title
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
EP0493362A3 (en) Compositions and kits for the treatment of oral diseases
AU573160B2 (en) Treatment of tissue degenerative inflammatory disease
AU2260088A (en) Methods and compositions for the treatment of lung conditions
AU6747887A (en) Treatment of skin disorders
AU2690684A (en) Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
AU551719B2 (en) Anthralin compositions for treatment of skin diseases
ZA898605B (en) Compositions for topical treatment of skin diseases
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
AU7549787A (en) Isoliquiritigenin for the treatment of kidney and liver diseases
AU590783B2 (en) Therapeutic agent for treating hematopoietic diseases
AU550675B2 (en) Pharmaceutical compositions for the treatment of skin
DE3570363D1 (en) Amino acid solution-containing drug for the treatment of cancerous diseases and preparation process thereof
GB8428747D0 (en) Products for treatment of human body
PT84755A (en) Process for the preparation of a pharmaceutical composition for the treatment of skin diseases
AU1541088A (en) Composition for the treatment of the epiderm
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
AU6360486A (en) Procedure for obtaining the preparation for the treatment of the disease psoriasis; drug for the treatment of psoriasis and its application
PL252062A1 (en) Method of obtaining pharmaceutical preparations exibiting prolonged therapeutic action
AU1306388A (en) Preparation for treatment of skin disorders
AU4864885A (en) Medicinal composition and method of treatment of periarthritis and similar diseases
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
EP0344820A3 (en) Means for the treatment of cardiac diseases
AU562435B2 (en) Substituted cyclopropenone for the treatment of alopecia areata and other dermatological diseases
AU605580C (en) Aerosolization of protein therapeutic agent